EU External Trade - Steroidal hormones, their derivatives and structural analogues, Oestrogens and progestogens

Extra-EU sourcing of Steroidal hormones, their derivatives and structural analogues, Oestrogens and progestogens is highly concentrated. 🇨🇳 China captures 51.2% of imports (€571.0M), followed by 🇮🇳 India (28.5%). With an HHI of 3616, this Concentrated market exposes the EU to supply dependency risks.

The EU exports Steroidal hormones, their derivatives and structural analogues, Oestrogens and progestogens to 6 extra-EU markets, reflecting solid diversification. 🇨🇭 Switzerland remains the largest client (22.0%, €191.3M), followed by 🇨🇭 Switzerland, 🇺🇸 United States, 🇮🇳 India.

Within the EU, 🇧🇪 Belgium concentrates 41.1% of Steroidal hormones, their derivatives and structural analogues, Oestrogens and progestogens imports, well ahead of 🇳🇱 Netherlands (30.6%). The top importing member states are 🇧🇪 Belgium, 🇳🇱 Netherlands, 🇮🇹 Italy.

In 2025, imports were falling sharply (-30.9%) and exports declining (-10.8%) compared to the previous year.